Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.

ABSTRACT:

SUBMITTER: Sherman EJ 

PROVIDER: S-EPMC9969528 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature